A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2011
11/29/2011	US8067030 Controlled release composition and method of producing the same
11/29/2011	US8067007 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
11/29/2011	US8067001 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/29/2011	US8066976 Foaming compositions for hair care
11/29/2011	US8066975 Psoriasis or seborrheic dermatitis; mixture of clobetasol propionate, an anionic surfactant (sodium lauryl ether sulfate), an amphoteric surfactant ( cocamidopropyl betaines); a propenetrating agent chosen from ethanol, isopropanol, propylene glycol and ethoxydiglycol; foam with good compactnes; shampoo
11/29/2011	US8066695 Implantable apparatus for administering a therapeutic agent into tissue
11/29/2011	CA2672000C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of lymphoma
11/29/2011	CA2613417C Pharmaceutical preparation containing an angiotensin ii receptor antagonist and a calcium channel blocker
11/29/2011	CA2569739C Antitumor effect potentiator, antitumor preparation, and method for treating cancer
11/29/2011	CA2494345C Combination of an aromatase inhibitor with a bisphosphonate
11/29/2011	CA2479711C Formulation
11/29/2011	CA2478645C Treatment of central nervous system damage
11/29/2011	CA2462580C Utilization of phosphatidylserine in the treatment of attention deficit syndrome (adhs)
11/29/2011	CA2461349C Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
11/29/2011	CA2449356C Process for preparing granular compositions
11/24/2011	WO2011146863A1 Surgical compositions containing sigma-receptor agonists
11/24/2011	WO2011146803A1 Method of treating lung adenocarcinoma with hsp90 inhibitory compounds
11/24/2011	WO2011145744A1 Anti-human trop-2 antibody having antitumor activity in vivo
11/24/2011	WO2011145723A1 Method for prevention or treatment of metabolic syndrome
11/24/2011	WO2011145056A1 Anti-viral agents and compositions thereof
11/24/2011	WO2011144721A1 Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
11/24/2011	WO2011144545A1 Theobromine for increasing hdl-cholesterol
11/24/2011	WO2011076841A3 Combination therapy for copd
11/24/2011	WO2011068703A3 Methods of modulating inflammation in preterm infants using carotenoids
11/24/2011	US20110288172 Dermatological compositions and methods
11/24/2011	US20110288156 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis
11/24/2011	US20110288019 Methods of increasing platelet and hematopoietic stem cell production
11/24/2011	US20110287420 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or WNT
11/24/2011	US20110287049 Prevention and treatment of amyloidogenic diseases
11/24/2011	US20110287029 Inhibition of the beta3 subunit of l-type ca2+ channels
11/24/2011	US20110287024 Vascular endothelial cell growth factor antagonists
11/24/2011	US20110286996 Antibiotics ge 81112 factors a, b, b1, pharmaceutically acceptable salts and compositions, and use thereof
11/24/2011	US20110286959 Copolymers for suppression of autoimmune diseases, and methods of use
11/24/2011	US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells
11/24/2011	CA2800015A1 Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
11/24/2011	CA2798911A1 Theobromine for increasing hdl-cholesterol
11/24/2011	CA2798778A1 Anti-human trop-2 antibody having anti-tumor activity in vivo
11/23/2011	EP2388590A1 PD-1, a receptor for B7-4, and uses thereof
11/23/2011	EP2388007A1 Compounds, formulations, and methods for treating or preventing rosacea
11/23/2011	EP2388005A1 Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
11/23/2011	EP2387405A2 Pirenzepine as an agent in cancer treatment
11/23/2011	EP2387404A2 Sgc stimulators of sgc activators in combination with pde5 inhbitors for the treatment of erectile dysfunction
11/23/2011	EP2387403A1 Method of treating cancer
11/23/2011	EP2387398A1 Fulvic acid in combination with fluconazole or amphotericin b for the treatment of fungal infections
11/23/2011	EP2387397A2 Methods for identifying patients who will respond well to cancer treatment
11/23/2011	EP2387390A2 Hylauronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation
11/23/2011	EP2194981B1 Bisbenzimidazoles as antimalarial agents
11/23/2011	EP2107906B1 Novel therapeutic use for treating leukaemia
11/23/2011	EP1716868B1 Anti-inflammatory analgesic for external use
11/23/2011	EP1671649B1 Dipeptidyl peptidase IV inhibitors for treating diabetic patients with sulfonylurea secondary failure
11/23/2011	EP1532269B1 1l1rl-1 as a cardiovascular disease marker
11/23/2011	EP1492780B1 5-substituted 1,1-dioxo-¬1,2,5 thiazolidine-3-one derivatives as ptpase 1b inhibitors
11/23/2011	EP1349576B1 Combined use of enzyme inhibitors for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological diseases associated with follicular and epidermal hyperkeratosis and reinforced keratinocyte proliferation
11/23/2011	CN1897973B Application of lactoferrin and polyinosinicacid in proliferation agent combinations of preparation of animal nature killer cells
11/23/2011	CN1671351B NSAID-containing topical formulations that demonstrate chemopreventive activity
11/23/2011	CN102256623A Neuroinvasion inhibitor
11/23/2011	CN102251317A Preparation method of electrospun fibers with controllable drug release
11/23/2011	CN102251013A Antibody and antigen for recognizing tumor initiator cell and application thereof
11/23/2011	CN102250277A Macromolecular polymer capable of carrying medicine and used for embolism
11/23/2011	CN102250074A Thiophene analogues for treatment or prevention of flavivirus infections
11/23/2011	CN102250071A Pyrazole compounds useful as protein kinase inhibitors
11/23/2011	CN102247605A Antiviral effect of novel pathogen recognition molecule
11/23/2011	CN102247602A Super-molecular hydrogel double-medicament carrier and preparation method as well as application thereof
11/23/2011	CN102247598A Oil-soluble drug composition
11/23/2011	CN102247597A Novel inhalant containing glucocorticoid and bronchodilator
11/23/2011	CN102247596A Application of 5-aminolevulinic acid (ALA) or its metabolites in preparing ultrasonic sensitive agent for medical purposes
11/23/2011	CN102247592A Novel application of ubiquitin-like modified protein in resisting virus
11/23/2011	CN102247315A OTC (Over the Counter) drug frozen sucker for treating symptoms of upper respiratory tract and oral cavity and preparation method thereof
11/23/2011	CN101568338B Novel therapeutic use for treating leukaemia
11/23/2011	CN101330930B Therapeutic agent for heart disease
11/22/2011	US8063081 Aryl carbonyl derivatives as therapeutic agents
11/22/2011	US8063022 Methods for preventing formation of inhibitory antibodies in the setting of gene therapy
11/22/2011	US8063013 Method of treating glaucoma comprising administering a composition comprising human BMP7
11/22/2011	US8062668 Stimuli-responsive systems for controlled drug delivery
11/22/2011	CA2489730C Use of mglur5 antagonists for the treatment of gerd
11/22/2011	CA2473874C A composition for treating neurocerebrovascular disorders
11/22/2011	CA2471974C Quinazolinone derivatives and their use as cb agonists
11/22/2011	CA2456025C An implantable and sealable system for unidirectional delivery of therapeutic agents to tissues
11/22/2011	CA2455392C Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same
11/22/2011	CA2449312C Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor
11/22/2011	CA2416808C Derivatives of branched-chain lipophilic molecules and uses thereof
11/22/2011	CA2416631C Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
11/22/2011	CA2372511C Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/22/2011	CA2313739C Model animals of human retrovirus infection
11/22/2011	CA2258518C Recognition molecules interacting specifically with the active site or cleft of a target molecule
11/17/2011	WO2011143614A1 Enhanced death receptor agonists
11/17/2011	WO2011142460A1 Method for detecting schizophrenia
11/17/2011	WO2011142425A1 Material for regeneration of epithelial-layer-containing tissue and method for evaluating regeneration
11/17/2011	WO2011141419A1 Association of the xanthine oxidase inhibitor febuxostat and metformin and use thereof
11/17/2011	WO2011141113A2 Combination of vitamin k and nicotinamide
11/17/2011	WO2011061252A3 Combination of alpha- 2 adrenergic receptor agonist and non-steroidal anti - inflammatory agent for treating or preventing an inflammatory skin disorder
11/17/2011	WO2011038278A3 Micelle encapsulation of therapeutic agents
11/17/2011	WO2011014850A3 Topical eutectic-based formulations
11/17/2011	WO2010140007A3 Tamper resistant dosage form comprising a matrix and melt - extruded particulates comprising a drug
11/17/2011	US20110281889 5-HT1A Receptor Subtype Agonist
11/17/2011	US20110281799 Vascular Endothelial Growth Factor D (VEGF-D) Antibodies and Vectors, and Methods of Uses
11/17/2011	US20110281021 Rapidly disintegrating dosage form for releasing active ingredients in the oral cavity or in body cavities
11/17/2011	US20110280903 Immunostimulatory combinations
11/17/2011	US20110280895 IMMUNOTHERAPEUTIC METHOD USING ALLO-CELLS WHICH CO-EXPRESS CD1d AND TARGET ANTIGEN
11/17/2011	US20110280870 Hepatocyte growth factor receptor antagonists and uses thereof

1 ... 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 ... 1151